Skip to main content

Table 2 Utility values of COVID-19 disease based on clinical characteristics

From: The health-related quality of life in Iranian patients with COVID-19

Sociodemographic and clinical characteristics Number (%) Utility value P-value
Mean (SE) Median (IQR)
Total 287 (100) 0.863 (0.01) 0.909 (0.21)  
Having underlying disease
 Yes 107 (37.28) 0.818 (0.02) 0.886 (0.26) <  0.01
 No 180 (62.72) 0.889 (0.01) 0.923 (0.08)
Patient’s condition
 Quarantine at home 123 (42.86) 0.896 (0.02) 0.98 (0.13) 0.01
 General wards hospitalized 147 (51.22) 0.847 (0.01) 0.886 (0.24)
 ICU hospitalized-non-intubated 13 (4.53) 0.766 (0.06) 0.808 (0.21)
 ICU hospitalized-intubated 4 (1.39) 0.629 (0.13) 0.727 (0.33)
Hospitalized days
 1 day 77 (26.83) 0.872 (0.02) 0.915 (0.19) 0.33
 1–4 days 115 (40.07) 0.875 (0.02) 0.931 (0.17)
 Over 4 days 95 (33.10) 0.840 (0.02) 0.896 (0.25)
Blood oxygen saturation
 Normal (over 95%) 70 (24.39) 0.881 (0.01) 0.904 (0.19) 0.33
 Below normal (under 95%) 217 (75.61) 0.857 (0.01) 0.923 (0.21)
Degree of lung involvement
 Non/minor involved 64 (22.30) 0.927 (0.01) 0.966 (0.11) <  0.01
 Poorly involved 190 (66.20) 0.844 (0.01) 0.894 (0.24)
 Moderately involved 28 (9.76) 0.859 (0.04) 0.969 (0.20)
 Severely involved 5 (1.74) 0.651 (0.11) 0.684 (0.24)
Perceived total health status (VASa)
 > 0.7 206 (71.78) 0.869 (0.01) 0.917 (0.17) 0.19
 0.5–0.7 23 (8.01) 0.894 (0.03) 0.969 (0.23)
 <  0.5 58 (20.21) 0.826 (0.02) 0.864 (0.26)
  1. aVisual Analogue Scale